Sound familiar? China/US biotech hybrid lands rights to cancer drugs, cash and a team of development vets to launch Oncologie
Looking for a new and suddenly popular business model?
Another transpacific biotech has launched with the backing of an emerging group of venture investors in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
